Company Description
Drug company AtheroGenics develops drug candidates for the treatment of chronic inflammatory diseases, including diabetes and coronary heart...
Headquarters:
8995 Westside Pkwy.Alpharetta, GA 30004
United States (Map)
Key AtheroGenics Financials
| Company Type | Public - OTC: AGIXQ Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.0 |
| 2008 Employees | 2 |
More AtheroGenics Financials (10 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about AtheroGenics's competition across multiple industries
Top AtheroGenics Competitors
Sponsored Links
The Business DirectoryAtheroGenics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Michael A. (Mike) Henos | Network | E-mail |
| President, CFO, and Secretary | Charles A. Deignan | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
